Optimising tissue acquisition and the molecular testing pathway for patients with non-small cell lung cancer: A UK expert consensus statement

Neal Navani, Rachel Butler, Salma Ibrahimo, Anjali Verma, Matthew Evans,Gary J Doherty,Samreen Ahmed

Lung Cancer（2022）

引用 1|浏览3

暂无评分

摘要

•Molecular testing is critical in patients with NSCLC to personalise therapy options.•Genomic Laboratory Hubs in England deliver genomic testing for NSCLC.•Challenges with genomic testing include tissue quality/quantity and turnaround times.•Recommendations include optimising sample acquisition/processing, MDT communication.

查看译文

关键词

Biomarkers,Genomic laboratory hub,Genomic testing in lung cancer,Molecular,Next‑generation sequencing,Targeted therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要